DK1289968T3 - Cykliske urinstofforbindelser og fremgangsmåde til fremstilling heraf - Google Patents

Cykliske urinstofforbindelser og fremgangsmåde til fremstilling heraf

Info

Publication number
DK1289968T3
DK1289968T3 DK01945420T DK01945420T DK1289968T3 DK 1289968 T3 DK1289968 T3 DK 1289968T3 DK 01945420 T DK01945420 T DK 01945420T DK 01945420 T DK01945420 T DK 01945420T DK 1289968 T3 DK1289968 T3 DK 1289968T3
Authority
DK
Denmark
Prior art keywords
compounds
carbamic acid
new
urea compounds
function
Prior art date
Application number
DK01945420T
Other languages
Danish (da)
English (en)
Inventor
Marc Rodriguez
Gilles Guichard
Serge Plaue
Vincent Semetey
Arnaud-Pierre Schaffner
Jean-Paul Briand
Original Assignee
Centre Nat Rech Scient
Immupharma France Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Immupharma France Sa filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of DK1289968T3 publication Critical patent/DK1289968T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/04—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Fats And Perfumes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01945420T 2000-06-13 2001-06-13 Cykliske urinstofforbindelser og fremgangsmåde til fremstilling heraf DK1289968T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0007507A FR2810039B1 (fr) 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation
PCT/FR2001/001837 WO2001096318A1 (fr) 2000-06-13 2001-06-13 Composes urees cycliques et leur procede de preparation

Publications (1)

Publication Number Publication Date
DK1289968T3 true DK1289968T3 (da) 2008-06-23

Family

ID=8851208

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01945420T DK1289968T3 (da) 2000-06-13 2001-06-13 Cykliske urinstofforbindelser og fremgangsmåde til fremstilling heraf

Country Status (13)

Country Link
US (1) US7186828B2 (enExample)
EP (2) EP1289968B1 (enExample)
JP (1) JP5054877B2 (enExample)
KR (1) KR20030031001A (enExample)
AT (1) ATE386728T1 (enExample)
AU (2) AU2001267645B2 (enExample)
CA (2) CA2412782C (enExample)
DE (1) DE60132891T2 (enExample)
DK (1) DK1289968T3 (enExample)
ES (1) ES2301554T3 (enExample)
FR (1) FR2810039B1 (enExample)
IL (1) IL153408A0 (enExample)
WO (1) WO2001096318A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101405276A (zh) * 2005-12-29 2009-04-08 安姆弗拉玛法国股份公司 用于抑制磷脂酶a2的组合物和方法
CA2635359A1 (en) * 2005-12-29 2007-07-05 Immupharma France Sa Compositions and methods for synthesizing heterocyclic therapeutic compounds
US20080031951A1 (en) 2005-12-29 2008-02-07 Gilles Guichard Compositions and methods for the inhibition of phospholipase A2
AU2006331357B2 (en) * 2005-12-29 2012-05-17 Immupharma France Sa Compositions and methods for synthesizing novel heterocyclic therapeutics
EP1965806B1 (en) * 2005-12-29 2010-08-11 Immupharma France Sa 1, 3, 5-triazepin-2, 6-diones for the treatment of malaria
US8563115B2 (en) * 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
EP2548869A1 (en) * 2011-07-20 2013-01-23 Cytec Technology Corp. Process for the Synthesis of N-substituted Cyclic Alkylene Ureas
CN102911130B (zh) * 2011-08-03 2015-05-20 北京师范大学 一种一锅法合成脲四元环化合物的方法、合成的脲四元环化合物
WO2015024955A1 (en) 2013-08-21 2015-02-26 Ureka Sarl Peptide-oligourea chimeric compounds and methods of their use
US10414722B2 (en) 2015-06-22 2019-09-17 Ureka Sarl Bioinspired catalysis using oligourea helical foldamers
US10233213B2 (en) 2015-08-31 2019-03-19 Ureka Sarl Foldamer helix bundle-based molecular encapsulation
US11267861B2 (en) 2016-04-19 2022-03-08 Ureka Sarl Peptide-oligourea foldamer compounds and methods of their use
US12434075B2 (en) * 2021-05-11 2025-10-07 Celestial Oncology Inc. Coupled robotic radiation therapy system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847760A1 (de) * 1978-11-03 1980-05-14 Hoechst Ag Verfahren zur herstellung von 1,3,5-triaza-2,4,6-triketo-cycloheptan- 3,5-di-essigsaeureestern
US4918186A (en) * 1986-05-06 1990-04-17 Mitsui Toatsu Chemicals, Inc. Process for producing cyclic ureas
AU2871592A (en) * 1991-10-11 1993-05-03 Du Pont Merck Pharmaceutical Company, The Cyclic ureas and analogues useful as retroviral protease inhibitiors
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5637780A (en) 1993-03-30 1997-06-10 The Dupont Merck Pharmaceutical Company Method for preparing alkylating agents and their use for alkylating cyclic ureas
US5508400A (en) * 1994-04-20 1996-04-16 The Du Pont Merck Pharmaceutical Company Preparation of cyclic urea compounds
EP0815108A1 (en) * 1995-03-17 1998-01-07 The Du Pont Merck Pharmaceutical Company Cyclic urea hiv protease inhibitors
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
AU1592697A (en) 1995-08-22 1997-03-19 Du Pont Merck Pharmaceutical Company, The Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors
HUP9904143A3 (en) 1996-11-08 2002-11-28 Du Pont Pharm Co (4r,5s,6s,7r)-hexahydro-1- [5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis [phenylmethyl] -2h-1,3-diazepin-2-one,its preparation and its use as hiv protease inhibitor

Also Published As

Publication number Publication date
ES2301554T3 (es) 2008-07-01
AU6764501A (en) 2001-12-24
CA2778314A1 (en) 2001-12-20
EP1640368A2 (fr) 2006-03-29
US7186828B2 (en) 2007-03-06
AU2001267645B2 (en) 2006-07-27
EP1640368A3 (fr) 2007-03-28
JP5054877B2 (ja) 2012-10-24
FR2810039A1 (fr) 2001-12-14
CA2412782A1 (en) 2001-12-20
CA2412782C (en) 2012-08-07
IL153408A0 (en) 2003-07-06
WO2001096318A8 (fr) 2003-05-01
DE60132891D1 (de) 2008-04-03
CA2778314C (en) 2017-01-03
EP1289968A1 (fr) 2003-03-12
JP2004503546A (ja) 2004-02-05
US20040044199A1 (en) 2004-03-04
ATE386728T1 (de) 2008-03-15
EP1289968B1 (fr) 2008-02-20
KR20030031001A (ko) 2003-04-18
FR2810039B1 (fr) 2007-05-25
WO2001096318A1 (fr) 2001-12-20
DE60132891T2 (de) 2009-03-19

Similar Documents

Publication Publication Date Title
DK1289968T3 (da) Cykliske urinstofforbindelser og fremgangsmåde til fremstilling heraf
NO305478B1 (no) Hydroksyetylaminosulfonamider som retrovirale proteasehemmere
ATE293127T1 (de) Synthetische peptidinhibitoren der hiv- übertragung
DE60214392D1 (de) 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
DK0727419T3 (da) Mellemprodukter til fremstilling af forbindelser, som inhiberer retroviral protease
UY27585A1 (es) Cis - imidazolinas
DE69729583D1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
PL322169A1 (en) Sulphonylalkanoylamino hydroxyethylaminosulphonamides as inhibitors of retroviral protease
DK0813542T3 (da) Aminosyrehydroxyethylaminosulfonamid som retrovirale proteaseinhibitorer
HUP9902818A3 (en) Compounds with anti-inflammatory and immunosuppressive activities
MX9706946A (es) Inhibidores de la proteasa retroviral de la hidroxietilaminosulfonamida de aminoacidos heterociclicocarbonilicos y uso de los mismos.
MXPA04004805A (es) Peptido novedoso que tiene un efecto inhibidor de la enzima convertidora de angiotensina.
DE3850550D1 (de) Dipeptide, verwendbar als Pflanzenwachstumsregulatoren.
CO4560412A1 (es) Piperidonas
BR0011546A (pt) Lata de aço inoxidável para aerossóis dosadores acionados por propelente
EP0796867A4 (en) Peptide, bronchodilator and blood flow ameliorant
CA2093202A1 (en) Sterilant gas mixture
NO952748D0 (no) Polypeptid som spesifikt inhiberer Cathepsin L.
NO972905L (no) Tienoksasinon-derivater anvendelige som antivirusmidler
NZ506667A (en) A process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues
NZ508812A (en) Peptides for the prevention or treatment of HIV
ES2167464T3 (es) Procedimiento para la preparacion de n-carboxianhidridos de aminoacidos a partir de n-(n'-nitrosocarbamoil)aminoacidos.
Li Burgess dehydrating reagent
岩元誠一 On the first subconstituent of a quadratic forms scheme
IT1317000B1 (it) Uso di composti di origine naturale ad attivita' antiangiogenica.